2,349 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by Riverbend Wealth Management LLC

Riverbend Wealth Management LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 2,349 shares of the healthcare conglomerate’s stock, valued at approximately $1,198,000. UnitedHealth Group comprises 1.1% of Riverbend Wealth Management LLC’s investment portfolio, making the stock its 23rd largest position.

Other institutional investors have also recently added to or reduced their stakes in the company. NewSquare Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $25,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Promus Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $32,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at approximately $37,000. Finally, Pillar Financial Advisors LLC acquired a new position in UnitedHealth Group during the 4th quarter worth $40,000. 87.86% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $479.14 on Tuesday. The company has a market cap of $438.28 billion, a P/E ratio of 30.91, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company’s fifty day moving average is $513.21 and its two-hundred day moving average is $552.69. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.83 EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.75%. UnitedHealth Group’s payout ratio is 54.19%.

Analyst Ratings Changes

UNH has been the subject of several research analyst reports. Oppenheimer upped their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. KeyCorp reiterated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Piper Sandler cut their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Finally, Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.